Skip to main content

Bedel Financial Consulting, Inc.

Position in GSK — GSK plc

CIK 1730511 INDIANAPOLIS, IN

Position in GSK

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$396,400
-$20,946 QoQ
Shares Held
7,562
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#530
of 1,033 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GSK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Bedel Financial Consulting, Inc. holds $404,013,991 across 11 Drug Manufacturers - General names. GSK ranks #8 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GSK
GSK plc
This page
7,562 $396,400

All Filings in GSK

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $396,400 7,562
2026-03-31 $417,346 7,562
2025-12-31 $370,840 7,562
2025-09-30 $326,375 7,562
2025-06-30 $290,380 7,562
2025-03-31 $292,951 7,562
2024-12-31 $255,746 7,562
2024-09-30 $309,584 7,573
2024-06-30 $291,137 7,562
2024-03-31 $324,182 7,562
2023-12-31 $280,247 7,562
2023-09-30 $249,617 6,886
2023-06-30 $245,417 6,886
2023-03-31 $230,914 6,490
2022-03-31 $8,886 208
2021-12-31 $2,335 54